FDA Recalls Transderm Scop Scopolamine Transdermal Patches for Temperature Deviation
McKesson Medical-Surgical is recalling Transderm Scop (scopolamine) transdermal patches nationwide due to Good Manufacturing Practice (cGMP) deviations involving temperature abuse during manufacturing. No illnesses have been reported.
- Product
- TRANSDERM SCOP — TRANSDERM SCOP (SCOPOLAMINE)
- Category
- Drug
- Distribution
- Distributed nationwide